DanDi Bioscience

https://www.businesspost.co.kr/BP?command=article_view&num=272995 

This post has been translated from the original article dated 2/28/2022. 

Dandi Bioscience (Dandi Bio), an affiliate of the HLB (HLB) Group, changes its name to HLB Science.

According to Dandi Bio on the 28th, it was decided to change the company name to ‘HLB Science Inc.’ through the regular shareholders’ meeting held on March 23rd.

  Dandibio name changed to HLB Science, new articles of association for issuance of exchangeable bonds

▲ Dandi Bio logo.

It is interpreted as a plan to strengthen its identity as an HLB group affiliate.

Dandi Bio also establishes a new clause in the articles of incorporation about the issuance of exchangeable bonds (up to 100 billion won). Previously, there were only provisions on convertible bonds and bonds with warrants.

Dandi Bio is a Konex-listed company that is developing septicemia treatment, Alzheimer's treatment, and immune booster. The largest shareholder is Next Science (54.11%), an HLB affiliate.

Next Science is a company controlled by HLB CEO Jin Yang-gon, and although it has no direct equity relationship with HLB, it is cooperating in various fields such as corporate acquisition. It is planned to change the company name to ‘HLB Global’ like Dandi Bio. [Business Post Reporter Lim Han-sol]